Global Over The Counter (OTC) Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 24-May-2019
No. of pages: 113
Inquire Before Buying

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

The global Over The Counter (OTC) Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Over The Counter (OTC) Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Over The Counter (OTC) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Over The Counter (OTC) Drugs in these regions.

This research report categorizes the global Over The Counter (OTC) Drugs market by top players/brands, region, type and end user. This report also studies the global Over The Counter (OTC) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Bayer AG

- Boehringer Ingelheim

- GlaxoSmithKline PLC

- Johnson & Johnson

- Novartis International AG

- Pfizer,Inc.

- PGT healthcare

- Sanofi S.A

- Takeda

Market size by Product

- Analgesics

- Dermatology Products

- Gastrointestinal Products

- Vitamins, Mineral, and Supplements (VMS)

- Weight Loss/Dietary Products

- Ophthalmic Products

- Sleeping Aids

- Others

Market size by End User

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacy

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Over The Counter (OTC) Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Over The Counter (OTC) Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Over The Counter (OTC) Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Over The Counter (OTC) Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Over The Counter (OTC) Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Over The Counter (OTC) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Over The Counter (OTC) Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Over The Counter (OTC) Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Product
1.4.2 Analgesics
1.4.3 Dermatology Products
1.4.4 Gastrointestinal Products
1.4.5 Vitamins, Mineral, and Supplements (VMS)
1.4.6 Weight Loss/Dietary Products
1.4.7 Ophthalmic Products
1.4.8 Sleeping Aids
1.4.9 Others
1.5 Market by End User
1.5.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacy
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Over The Counter (OTC) Drugs Market Size
2.1.1 Global Over The Counter (OTC) Drugs Revenue 2014-2025
2.1.2 Global Over The Counter (OTC) Drugs Sales 2014-2025
2.2 Over The Counter (OTC) Drugs Growth Rate by Regions
2.2.1 Global Over The Counter (OTC) Drugs Sales by Regions
2.2.2 Global Over The Counter (OTC) Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Over The Counter (OTC) Drugs Sales by Manufacturers
3.1.1 Over The Counter (OTC) Drugs Sales by Manufacturers
3.1.2 Over The Counter (OTC) Drugs Sales Market Share by Manufacturers
3.1.3 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Over The Counter (OTC) Drugs Revenue by Manufacturers
3.2.1 Over The Counter (OTC) Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Over The Counter (OTC) Drugs Price by Manufacturers
3.4 Over The Counter (OTC) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Over The Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over The Counter (OTC) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Over The Counter (OTC) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Over The Counter (OTC) Drugs Sales by Product
4.2 Global Over The Counter (OTC) Drugs Revenue by Product
4.3 Over The Counter (OTC) Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Over The Counter (OTC) Drugs Breakdown Data by End User
6 North America
6.1 North America Over The Counter (OTC) Drugs by Countries
6.1.1 North America Over The Counter (OTC) Drugs Sales by Countries
6.1.2 North America Over The Counter (OTC) Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Over The Counter (OTC) Drugs by Product
6.3 North America Over The Counter (OTC) Drugs by End User
7 Europe
7.1 Europe Over The Counter (OTC) Drugs by Countries
7.1.1 Europe Over The Counter (OTC) Drugs Sales by Countries
7.1.2 Europe Over The Counter (OTC) Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Over The Counter (OTC) Drugs by Product
7.3 Europe Over The Counter (OTC) Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Over The Counter (OTC) Drugs by Countries
8.1.1 Asia Pacific Over The Counter (OTC) Drugs Sales by Countries
8.1.2 Asia Pacific Over The Counter (OTC) Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Over The Counter (OTC) Drugs by Product
8.3 Asia Pacific Over The Counter (OTC) Drugs by End User
9 Central & South America
9.1 Central & South America Over The Counter (OTC) Drugs by Countries
9.1.1 Central & South America Over The Counter (OTC) Drugs Sales by Countries
9.1.2 Central & South America Over The Counter (OTC) Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Over The Counter (OTC) Drugs by Product
9.3 Central & South America Over The Counter (OTC) Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Over The Counter (OTC) Drugs by Countries
10.1.1 Middle East and Africa Over The Counter (OTC) Drugs Sales by Countries
10.1.2 Middle East and Africa Over The Counter (OTC) Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Over The Counter (OTC) Drugs by Product
10.3 Middle East and Africa Over The Counter (OTC) Drugs by End User
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Company Business Overview
11.1.3 Bayer AG Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Bayer AG Over The Counter (OTC) Drugs Products Offered
11.1.5 Bayer AG Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Company Business Overview
11.2.3 Boehringer Ingelheim Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Boehringer Ingelheim Over The Counter (OTC) Drugs Products Offered
11.2.5 Boehringer Ingelheim Recent Development
11.3 GlaxoSmithKline PLC
11.3.1 GlaxoSmithKline PLC Company Details
11.3.2 Company Business Overview
11.3.3 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GlaxoSmithKline PLC Over The Counter (OTC) Drugs Products Offered
11.3.5 GlaxoSmithKline PLC Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Business Overview
11.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Johnson & Johnson Over The Counter (OTC) Drugs Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis International AG
11.5.1 Novartis International AG Company Details
11.5.2 Company Business Overview
11.5.3 Novartis International AG Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Novartis International AG Over The Counter (OTC) Drugs Products Offered
11.5.5 Novartis International AG Recent Development
11.6 Pfizer,Inc.
11.6.1 Pfizer,Inc. Company Details
11.6.2 Company Business Overview
11.6.3 Pfizer,Inc. Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Pfizer,Inc. Over The Counter (OTC) Drugs Products Offered
11.6.5 Pfizer,Inc. Recent Development
11.7 PGT healthcare
11.7.1 PGT healthcare Company Details
11.7.2 Company Business Overview
11.7.3 PGT healthcare Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 PGT healthcare Over The Counter (OTC) Drugs Products Offered
11.7.5 PGT healthcare Recent Development
11.8 Sanofi S.A
11.8.1 Sanofi S.A Company Details
11.8.2 Company Business Overview
11.8.3 Sanofi S.A Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Sanofi S.A Over The Counter (OTC) Drugs Products Offered
11.8.5 Sanofi S.A Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Company Business Overview
11.9.3 Takeda Over The Counter (OTC) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Takeda Over The Counter (OTC) Drugs Products Offered
11.9.5 Takeda Recent Development
12 Future Forecast
12.1 Over The Counter (OTC) Drugs Market Forecast by Regions
12.1.1 Global Over The Counter (OTC) Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Regions 2019-2025
12.2 Over The Counter (OTC) Drugs Market Forecast by Product
12.2.1 Global Over The Counter (OTC) Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Over The Counter (OTC) Drugs Revenue Forecast by Product 2019-2025
12.3 Over The Counter (OTC) Drugs Market Forecast by End User
12.4 North America Over The Counter (OTC) Drugs Forecast
12.5 Europe Over The Counter (OTC) Drugs Forecast
12.6 Asia Pacific Over The Counter (OTC) Drugs Forecast
12.7 Central & South America Over The Counter (OTC) Drugs Forecast
12.8 Middle East and Africa Over The Counter (OTC) Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Over The Counter (OTC) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Over The Counter (OTC) Drugs Product Picture
Table Over The Counter (OTC) Drugs Market Segments
Table Key Manufacturers Over The Counter (OTC) Drugs Covered
Table Global Over The Counter (OTC) Drugs Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Over The Counter (OTC) Drugs Sales Market Share by Product 2014-2025
Figure Analgesics Product Picture
Table Major Manufacturers of Analgesics
Figure Dermatology Products Product Picture
Table Major Manufacturers of Dermatology Products
Figure Gastrointestinal Products Product Picture
Table Major Manufacturers of Gastrointestinal Products
Figure Vitamins, Mineral, and Supplements (VMS) Product Picture
Table Major Manufacturers of Vitamins, Mineral, and Supplements (VMS)
Figure Weight Loss/Dietary Products Product Picture
Table Major Manufacturers of Weight Loss/Dietary Products
Figure Ophthalmic Products Product Picture
Table Major Manufacturers of Ophthalmic Products
Figure Sleeping Aids Product Picture
Table Major Manufacturers of Sleeping Aids
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Over The Counter (OTC) Drugs Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacy
Figure Others
Figure Over The Counter (OTC) Drugs Report Years Considered
Figure Global Over The Counter (OTC) Drugs Market Size 2014-2025 (Million US$)
Figure Global Over The Counter (OTC) Drugs Sales 2014-2025 (K MT)
Table Global Over The Counter (OTC) Drugs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Over The Counter (OTC) Drugs Sales by Regions 2014-2019 (K MT)
Table Global Over The Counter (OTC) Drugs Sales Market Share by Regions 2014-2019
Figure Global Over The Counter (OTC) Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Over The Counter (OTC) Drugs Sales Market Share by Regions
Table Global Over The Counter (OTC) Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Over The Counter (OTC) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Over The Counter (OTC) Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Over The Counter (OTC) Drugs Revenue Market Share by Regions
Table Global Over The Counter (OTC) Drugs Sales by Manufacturers (2014-2019) (K MT)
Table Global Over The Counter (OTC) Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Over The Counter (OTC) Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Over The Counter (OTC) Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2014-2019)
Figure Over The Counter (OTC) Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Over The Counter (OTC) Drugs Price (2014-2019) (USD/MT)
Table Over The Counter (OTC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Over The Counter (OTC) Drugs Product Type
Table Date of International Manufacturers Enter into Over The Counter (OTC) Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Over The Counter (OTC) Drugs Sales by Product (2014-2019) (K MT)
Table Global Over The Counter (OTC) Drugs Sales Share by Product (2014-2019)
Figure Global Over The Counter (OTC) Drugs Sales Market Share by Product (2014-2019)
Figure Global Over The Counter (OTC) Drugs Sales Market Share by Product in 2018
Table Global Over The Counter (OTC) Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Over The Counter (OTC) Drugs Revenue Share by Product (2014-2019)
Figure Global Over The Counter (OTC) Drugs Revenue Market Share by Product (2014-2019)
Figure Global Over The Counter (OTC) Drugs Revenue Market Share by Product in 2018
Table Over The Counter (OTC) Drugs Price by Product 2014-2019 (USD/MT)
Table Global Over The Counter (OTC) Drugs Sales by End User (2014-2019) (K MT)
Table Global Over The Counter (OTC) Drugs Sales Share by End User (2014-2019)
Figure Global Sales Over The Counter (OTC) Drugs Market Share by End User (2014-2019)
Figure Global Sales Over The Counter (OTC) Drugs Market Share by End User in 2018
Figure North America Over The Counter (OTC) Drugs Sales Growth Rate 2014-2019 (K MT)
Figure North America Over The Counter (OTC) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Over The Counter (OTC) Drugs Sales by Countries (2014-2019) (K MT)
Table North America Over The Counter (OTC) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Over The Counter (OTC) Drugs Sales Market Share by Countries
Table North America Over The Counter (OTC) Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Over The Counter (OTC) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Over The Counter (OTC) Drugs Revenue Market Share by Countries
Figure United States Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure United States Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Canada Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Over The Counter (OTC) Drugs Sales by Product (2014-2019) (K MT)
Table North America Over The Counter (OTC) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Over The Counter (OTC) Drugs Market Share by Product
Table North America Over The Counter (OTC) Drugs Sales by End User (2014-2019) (K MT)
Table North America Over The Counter (OTC) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Over The Counter (OTC) Drugs Market Share by End User
Figure Europe Over The Counter (OTC) Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Europe Over The Counter (OTC) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Over The Counter (OTC) Drugs Sales by Countries (2014-2019) (K MT)
Table Europe Over The Counter (OTC) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Over The Counter (OTC) Drugs Sales Market Share by Countries
Table Europe Over The Counter (OTC) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Over The Counter (OTC) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Over The Counter (OTC) Drugs Revenue Market Share by Countries
Figure Germany Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Germany Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure France Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure UK Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Italy Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Russia Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Over The Counter (OTC) Drugs Sales by Product (2014-2019) (K MT)
Table Europe Over The Counter (OTC) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Over The Counter (OTC) Drugs Market Share by Product
Table Europe Over The Counter (OTC) Drugs Sales by End User (2014-2019) (K MT)
Table Europe Over The Counter (OTC) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Over The Counter (OTC) Drugs Market Share by End User
Figure Asia Pacific Over The Counter (OTC) Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Over The Counter (OTC) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Over The Counter (OTC) Drugs Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Countries
Table Asia Pacific Over The Counter (OTC) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Over The Counter (OTC) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Over The Counter (OTC) Drugs Revenue Market Share by Countries
Figure China Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure China Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Japan Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Korea Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure India Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Australia Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Over The Counter (OTC) Drugs Sales by Product (2014-2019) (K MT)
Table Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Over The Counter (OTC) Drugs Market Share by Product
Table Asia Pacific Over The Counter (OTC) Drugs Sales by End User (2014-2019) (K MT)
Table Asia Pacific Over The Counter (OTC) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Over The Counter (OTC) Drugs Market Share by End User
Figure Central & South America Over The Counter (OTC) Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Over The Counter (OTC) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Over The Counter (OTC) Drugs Sales by Countries (2014-2019) (K MT)
Table Central & South America Over The Counter (OTC) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Over The Counter (OTC) Drugs Sales Market Share by Countries
Table Central & South America Over The Counter (OTC) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Over The Counter (OTC) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Over The Counter (OTC) Drugs Revenue Market Share by Countries
Figure Brazil Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Over The Counter (OTC) Drugs Sales by Product (2014-2019) (K MT)
Table Central & South America Over The Counter (OTC) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Over The Counter (OTC) Drugs Market Share by Product
Table Central & South America Over The Counter (OTC) Drugs Sales by End User (2014-2019) (K MT)
Table Central & South America Over The Counter (OTC) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Over The Counter (OTC) Drugs Market Share by End User
Figure Middle East and Africa Over The Counter (OTC) Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Over The Counter (OTC) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Over The Counter (OTC) Drugs Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Countries
Table Middle East and Africa Over The Counter (OTC) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Over The Counter (OTC) Drugs Revenue Market Share by Countries
Figure GCC Countries Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Over The Counter (OTC) Drugs Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Over The Counter (OTC) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Over The Counter (OTC) Drugs Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Over The Counter (OTC) Drugs Market Share by Product
Table Middle East and Africa Over The Counter (OTC) Drugs Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Over The Counter (OTC) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Over The Counter (OTC) Drugs Market Share by End User
Table Bayer AG Company Details
Table Bayer AG Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Bayer AG Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table GlaxoSmithKline PLC Company Details
Table GlaxoSmithKline PLC Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline PLC Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis International AG Company Details
Table Novartis International AG Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis International AG Recent Development
Table Pfizer,Inc. Company Details
Table Pfizer,Inc. Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer,Inc. Recent Development
Table PGT healthcare Company Details
Table PGT healthcare Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table PGT healthcare Recent Development
Table Sanofi S.A Company Details
Table Sanofi S.A Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi S.A Recent Development
Table Takeda Company Details
Table Takeda Over The Counter (OTC) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Takeda Recent Development
Table Global Over The Counter (OTC) Drugs Sales Forecast by Regions 2019-2025 (K MT)
Table Global Over The Counter (OTC) Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Over The Counter (OTC) Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Over The Counter (OTC) Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Over The Counter (OTC) Drugs Sales Forecast by Product 2019-2025 (K MT)
Table Global Over The Counter (OTC) Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Over The Counter (OTC) Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Over The Counter (OTC) Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Over The Counter (OTC) Drugs Sales Forecast by End User 2019-2025 (K MT)
Table Global Over The Counter (OTC) Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Over The Counter (OTC) Drugs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Over The Counter (OTC) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Over The Counter (OTC) Drugs Value Chain
Table Over The Counter (OTC) Drugs Customers List
Table Over The Counter (OTC) Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs